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Summary 
 
Decompressive craniectomy (DC) is used for the treatment of posttraumatic brain 
injury raised intracranial pressure. Cranioplasty is a reconstructive procedure that 
restores the structural integrity of the skull following (DC). Seizures are a recognised 
complication of cranioplasty but its incidence and risk factors in TBI patients are 
unclear. Accurate prognostication can help direct prophylactic and treatment 
strategies for seizures. In this systematic review, we aim to evaluate current 
literature on these factors. A PROSPERO-registered systematic review was 
performed in accordance with PRISMA guidelines. Data was synthesised 
qualitatively and quantitatively in meta-analysis where appropriate. 
A total of 8 relevant studies were identified, reporting 919 cranioplasty 
patients. Random-effects meta-analysis reveals a pooled incidence of post-
cranioplasty seizures (PCS) of 5.1% (95% CI 2.6-8.2%).  Identified risk factors from 
a single study included increasing age (OR 6.1, p = 0.006), contusion at cranioplasty 
location (OR 4.8, p = 0.015), and use of monopolar diathermy at cranioplasty (OR 
3.5, p = 0.04).  There is an association between an extended DC-cranioplasty 
interval and PCS risk although it did not reach statistical significance (p = 0.062). 
Predictive factors for PCS are poorly investigated in the TBI population to 
date. Heterogeneity of included studies preclude meta-analysis of risk factors.  
Further studies are required to define the true incidence of PCS in TBI and its 
predictors, and trials are needed to inform management of these patients. 
 
Keywords: neurotrauma; epilepsy; post-traumatic seizures  
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Key Points 
• Seizures are a recognised complication of cranioplasty after TBI 
• Meta-analysis shows estimated incidence of 5.1%  
• Potential risk factors include age, contusions at cranioplasty site, monopolar 
diathermy, and DC-cranioplasty interval 
 
 
 
 
 
Introduction 
 
Traumatic brain injury (TBI) is a common neurosurgical presentation, with a variable 
clinical phenotype depending on the severity and anatomy of injury1; 2.  A proportion 
of TBI patients develop uncontrollable raised intracranial pressure (ICP).  In this 
group, an increasingly common surgical management option is decompressive 
craniectomy (DC), involving the removal of a bone flap to allow the brain to swell 
while relieving ICP3; 4.  The removed flap may be stored in an abdominal pouch or a 
specialised refrigeration unit, or discarded depending on factors such as infection 
and surgeon preference5; 6.   
 
After acute swelling of the brain resolves, cranioplasty is performed to restore the 
integrity of the skull and cerebrospinal fluid dynamics7. It is also an important factor 
in restoring psychosocial functioning of the patient, and allowing subsequent 
rehabilitation. Depending on patient factors and surgeon preference, the skull may 
be reconstructed using the bone flap removed during DC (autologous), or synthetic 
materials such as polyetheretherketone (PEEK) and titanium5; 8; 9.  The benefits and 
risks associated with different cranioplasty materials are an area of active ongoing 
research8; 10.  Another variable that may be associated with complications is the DC 
to cranioplasty interval – although there is conflicting evidence on the nature of this 
relationship 11.  
 
Seizures are a recognised complication of cranioplasty4; 12.  While TBI itself is known 
to cause epilepsy in some patients2; 13, increasing evidence suggests that 
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cranioplasty can also cause new-onset seizures14.  Some patients may develop 
status epilepticus, a life-threatening condition that may require critical care 
admission, or epilepsy requiring long-term regular medication and associated 
lifestyle modification15.  Therefore, understanding the factors that predispose TBI 
patients undergoing cranioplasty to having seizures can help inform decisions 
regarding perioperative prophylactic antiepileptic medications16. Furthermore, given 
that cranioplasty is often performed at a point when patients are safe for discharge or 
transfer from the neurosurgical unit, it is important that the potential for new onset 
seizures is appreciated by the wider healthcare team. Previously proposed risk 
factors for PCS have included increasing age, sex, severity of initial trauma, DC-
cranioplasty interval, and the cranioplasty implant material8; 17; 18. This systematic 
review aims to define risk factors for the development of PCS and the incidence of 
PCS in TBI patients. 
 
 
Methods 
 
This systematic review was performed in line with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines19.  The protocol was 
registered on the PROSPERO database (CRD42017077310).   
 
Search Strategy 
A multi-database (Medline, EMBASE, Web of Science) search was performed by 
authors RS and MZ on 23/05/2018 for articles published at any time. Difference of 
opinion on study inclusion was settled by consensus between authors. The search 
terms used were ‘cranioplasty’ or ‘post-cranioplasty’ AND ‘seizure*’ or ‘epilep*’ or 
‘fits’ AND ‘traumatic brain injury’ or ‘TBI’ or ‘head injury’.  The bibliography of each 
relevant paper was subsequently screened to identify any additional articles. 
 
Study Selection 
Strict inclusion and exclusion criteria were defined prior to searching the literature.  
Inclusion criteria included (i) DC followed by cranioplasty in a TBI cohort, (ii) age>16, 
(iii) data on any risk factors such as age, gender, severity of TBI, DC-cranioplasty 
interval and cranioplasty material (Table 1).  
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Data Analysis 
All included studies were evaluated with respect to patient demographics; injury-
related factors (severity, radiological features); surgery-related factors (including 
peri-operative complications); DC-cranioplasty interval; incidence of seizures; timing 
of seizure onset in relation to cranioplasty; nature of seizures and the cranioplasty 
implant material used.  Meta-analysis was conducted using OpenMeta-Analyst 
software20.  The ROBINS-I tool was used by authors SM, FS and IB independently to 
assess the internal validity and risk of bias in each study21.  The level of evidence of 
each study was defined using the 2011 Oxford Centre for Evidence-Based Medicine 
Levels of Evidence22. 
 
 
Table 1- study selection criteria 
 
Inclusion Criteria Exclusion Criteria 
Patients underwent DC following 
traumatic brain injury 
Published in a language other than 
English 
Patients aged 16 or over at time of 
cranioplasty 
Conference abstracts 
Includes data on any of the following: 
• Age, gender 
• Severity of trauma (defined 
clinically or radiologically) 
• Presence of neurological deficit 
• DC to cranioplasty interval 
• Infection at any time point 
• Cranioplasty implant material 
Underlying pathology other than TBI 
included such that TBI patients cannot 
be distinguished from the general cohort 
Considers complications after 
cranioplasty including seizures 
Paediatric patients included such that 
the adult population cannot be 
distinguished from the general cohort 
Any full text article of any study type 
including case reports and case series 
 
 
 
Results 
 
A total of ten studies met the selection criteria3; 4; 12; 14; 18; 23-27. Two of these studies3; 
12 were excluded after closer inspection due to duplication of data in another paper23.  
Therefore, a total of 8 studies were included for final evaluation (Figure 1)19.  
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Study characteristics 
Included studies were predominantly retrospective database reviews (n=6), one 
prospective cohort study, and one study reporting a mixture of retrospective and 
prospective data (Table 2). Two studies reported cranioplasty for any indication, but 
identified the cases of PCS within their TBI cohort18; 26.  Some papers (n=5) reported 
only an incidence of PCS without any analysis of predictive factors4; 18; 23; 26; 27, while 
remaining papers disaggregated the PCS cases from controls for factors such as 
baseline demographics, DC-cranioplasty interval and intra-operative techniques, 
allowing analysis of risk factors14; 24; 25.   
 
 
 
 
Figure 1- PRISMA flow diagram demonstrating the study selection process. 
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Table 2- Relevant data extracted from each included study. *indicates that these odds ratios are not given in the paper but 
calculated by the present authors from the data given.  †note that the cut-off for early vs late cranioplasty is different between these 
papers.  PCS: post-cranioplasty seizures, OR: odds ratio, CI: confidence interval, Ti: Titanium plate cranioplasty, FND: focal 
neurological deficit. 
 
Study Type  Number of patients Number with PCS Risk factors OR (95% CI) P-value 
Broughton 2014 Retrospective database 
review 
40 0 - - - 
Honeybul 2014 Partly retrospective, 
partly prospective 
230 19 - - - 
Luo 2012 Retrospective database 
review 
161 5 Manually-shaped Ti 
(vs computer-shaped) 
0.70 (0.11-4.32)* 0.70 
Pierson 2016 Retrospective database 
review 
24 1 - - - 
Songara 2016 Prospective cohort 
study 
16 0 - - - 
Stephens 2010 Retrospective database 
review 
108 3 - - - 
 9 
Wang 2017 Retrospective case-
control study 
270 32 Age >50 6.112 (1.956-
19.099) 
0.006 
Contusion at 
cranioplasty location 
4.82 (1.414-17.432) 0.015 
Precranioplasty FND 0.258 (0.081-0.821) 0.019 
Artificial duraplasty 
(vs autologous fascia) 
0.206 (0.626-14.441 0.007 
Use of monopolar 
diathermy 
3.456 (1.067-9.732) 0.035 
Early cranioplasty 
(<6/12)† 
0.359 (0.119-1.085) 0.062 
Zhang 2010 Comparative analysis 70 4 Early cranioplasty 
(<3/12)† 
0.681 (0.067-
6.914)* 
0.745 
Total 
 
919 64 
   
 
 
 
 
Patient cohort 
In total, 919 patients who underwent cranioplasty following DC for TBI were reported.  
In studies reporting mean age (n=3), the average age was 39.1 years (448 
patients)4; 14; 25.  In studies reporting median age (n=2), the reported medians were 
42 (40 patients)26 and 30 (230 patients)23.  Two studies reported only an age range 
of their patients, overall age 16-71 (177 patients)24; 27.  One study reported age in its 
whole cohort of cranioplasty patients but did not report that of its TBI subgroup18.  
Five studies reported gender (625 patients), with 75.0% being male4; 14; 24; 25; 27.  Few 
studies reported measures of TBI severity in their cohort of patients.  Two studies 
reported mean Glasgow Coma Score (GCS) prior to cranioplasty, with an overall 
mean of 7.72 (86 patients)25; 27.  One study reported mean GCS prior to initial DC in 
their cohort of 108 patients at 7.54.  The remaining studies (n=5) did not report 
baseline GCS or other parameters indicating TBI severity. 
 
 
Incidence of PCS 
Across included studies, 7.0% (64 out of 919 patients) developed new-onset 
seizures following cranioplasty. A random-effects meta-analysis was performed, 
demonstrating an overall estimate of PCS incidence at 5.1% (95% CI 2.6-8.2%) (see 
Figure 2).  Only one paper (270 patients, 32 with PCS) reported the timing of new-
onset seizures after cranioplasty, finding 37.5% occurred within 24 hours; 15.6% 
between 24 hours and seven days; and 46.8% more than seven days post-
operatively14. 
 
 
 
 
 
 
 
 
 
 
Figure 2- Forest plot demonstrating the pooled incidence of PCS using the Freeman Tukey Double Arcsine Proportion in a 
random-effects model.  
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Risk factors 
Three studies disaggregated the features of their PCS patients from controls, 
allowing for analysis of predictive factors14; 24; 25.  Three studies investigated 
complication rates comparing early and late cranioplasty with respect to DC14; 25; 27.  
One study (16 patients) reported an absence of seizures within their one month 
follow up period, in both early and late cranioplasty groups27. 
 
While the other two studies did observe seizures in their cohorts, their defined cut-off 
between ‘early’ and ‘late’ cranioplasty was different, at three months25 and six 
months14, preventing meta-analysis.  The first study (70 patients) compared the 
frequency of PCS in patients with DC-cranioplasty interval <3 months with those >3 
months, and compared the effect of suturing the dura during DC.  No significant 
difference was seen in frequency of PCS when comparing these groups25.  The 
other study (270 patients) demonstrated a potential effect of late cranioplasty (>6 
months) on PCS in multivariate analysis, but this did not reach statistical significance 
(p=0.062)14.  In addition, this particularly increased risk of immediate and early (<7 
days) seizures compared to late ones, but statistical significance was not reported14. 
 
One study (161 patients) compared the outcomes of two methods for shaping 
titanium plate used for cranioplasty in a non-randomised study24.  The frequency of 
PCS was not significantly different between the computer-shaped and manually-
shaped groups.  Other studies (n=4) included patients with a mix of autologous, 
titanium and synthetic cranioplasty materials, but frequency of PCS in each 
subgroup was not delineated4; 18; 23; 26. 
 
One study (270 patients) employed a case-control design comparing PCS patients 
with healthy controls on multivariate analysis14.  The significant independent 
predictive factors were age>50, contusion at location of cranioplasty, or focal 
neurological deficit prior to cranioplasty (Table 2).  No significant effect of 
cranioplasty infection on PCS risk was seen (OR 3.01, 95% CI 0.626-14.441)14. 
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Level of evidence and risk of bias 
With respect to level of evidence, all included studies were level 4.  Of included 
studies, five were at moderate risk of bias, two were at serious risk and one was low 
(see Table 3).  Serious risk of bias was assigned to one study due to very short 
follow up time27, and to another because it did not account for confounding between 
study groups, did not report follow up time and was unclear whether patients were 
randomly allocated to the different intervention groups25.  The reasons for papers 
being assigned a moderate risk of bias was retrospective data collection, and a 
variable follow up time within their cohorts. 
 
 
Table 3- Risk of bias assessments using the ROBINS-I tool.  
 
 
Study Overall risk of bias 
regarding PCS 
Broughton 2014 Moderate 
Honeybul 2014 Moderate 
Luo 2012 Moderate 
Pierson 2016 Moderate 
Songara 2016 Serious 
Stephens 2010 Moderate 
Wang 2017 Low 
Zhang 2010 Serious 
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Discussion 
 
Seizures are an important complication after TBI, as well as after cranioplasty.  
Uncertainty remains regarding management of PCS and the provision of prophylactic 
anti-epileptic medication.  In this systematic review, we aimed to investigate potential 
risk factors and the incidence of PCS in the TBI cohort of cranioplasty patients.   
 
Incidence of PCS 
 
Our meta-analysis demonstrates a PCS incidence of 5.1% in the TBI cohort of 
patients. Observed statistical heterogeneity and paucity of high quality, prospective 
studies with sufficient follow up periods affect the reliability of this estimate.  Indeed, 
several recent prospective studies of PCS in cohorts of mixed underlying pathology 
have found incidences in the range 12.5-17.3%8; 16; 28; 29.  However, these PCS 
incidence in the TBI cohort alone cannot be deduced from these studies. Also, 
several studies that investigate the complications of PCS do not explore the 
incidence of seizures30-33.  This may reflect a lack of recognition of PCS as a 
procedural complication, or that seizures were not observed in these series. The 
incidence of post-traumatic seizures in severe TBI is 13.6%2. 
 
Patient Demographics 
 
The demographic of the patient cohort in this review is consistent with the larger TBI 
population, with a male preponderance and an average age of approximately 40 
years34.  Only one included study examined the effect of age on PCS risk, 
demonstrating that age over 50 years was associated with greater risk in multivariate 
regression (OR 6.1)14.  This association with increasing age has been reproduced in 
studies of PCS with mixed underlying pathology17, and increasing age has been 
shown to increase risk of complications of cranioplasty in general35. Studies of 
cranioplasty patients with various underlying pathologies have demonstrated 
associations between male gender and risk of PCS17; 36.  We did not find a similar 
effect in the TBI cohort, which may be a result of the male preponderance.  
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Severity of TBI 
 
Current evidence suggests that severity of trauma is predictive of risk of post-
traumatic seizures2. However, included studies did not provide sufficient details to 
allow analysis of the effect of severity of TBI on risk of PCS. Interestingly, Wang et al 
demonstrated that focal neurological deficit prior to cranioplasty was associated with 
a reduced risk of PCS14. In contrast, one study of cranioplasty patients with mixed 
underlying pathology demonstrated the opposite; presence of neurological deficit 
was associated with an increased risk of PCS37.  Further studies are required to 
clarify (i) the relationship between severity of trauma and PCS, and (ii) whether 
neurological deficit correlates with risk of PCS in a pathology dependent manner. 
Also, Wang et al found that presence of cerebral contusion at the cranioplasty site 
increased risk of PCS14.  It is known that patients with cerebral contusions and 
resulting neuroinflammation are at greater risk of post-traumatic seizures38. 
However, these findings suggest that the mechanical forces applied during the 
cranioplasty procedure itself could further increase risk of seizure activity originating 
at the site.   
 
Timing of Cranioplasty 
Our review suggests that a greater DC-cranioplasty interval is associated with an 
increased PCS risk14; 25, although this did not reach statistical significance. This trend 
is consistent with other studies demonstrating an association between early 
cranioplasty and improved outcomes across several measures27; 29.  One study 
explored the effect of cranioplasty timing on risk of complications in a mixed 
pathology cohort39. They demonstrated that risk of complications was maximal when 
cranioplasty was performed between 100 – 136 days following DC and fell after this 
timepoint. However, only one patient in this series suffered from PCS, experiencing 
status epilepticus after receiving the cranioplasty within 30 days of DC39. In contrast, 
a meta-analysis demonstrated no significant association between the length of delay 
prior to cranioplasty and the risk of PCS in patients with mixed underlying 
pathology11. Further studies are required to evaluate the relationship between DC-
cranioplasty interval and risk of PCS in TBI patients.  
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Cranioplasty Implant Material 
 
There are now a large variety of materials available for cranioplasty, including 
autologous bone, titanium sheet/mesh, polyetheretherketone (PEEK) and 
polymethylmethacrylate (PMMA).  However, the benefits and risks associated with 
use of different materials in the TBI cohort remain to be evaluated.  Four of the eight 
included studies performed cranioplasties with varying materials4; 18; 23; 26. None of 
these studies assessed the risk of post-cranioplasty complications with respect to 
implant material used. One study compared manually and computer-shaped titanium 
implants with respect to post cranioplasty complications24. There was no significant 
difference in PCS incidence between groups. The effect of implant material on post-
cranioplasty complications is explored more extensively in the literature in the 
context of various underlying pathologies.  Despite significant differences being 
observed in terms of risk of post-operative infection9, differences in risk of PCS have 
not been demonstrated8; 17; 42; 43.   
 
Infection 
 
Current evidence demonstrates a possible role for infection as a risk factor for PCS 
in mixed pathologies17. Of included studies, one study explored the relationship 
between infection at the cranioplasty site and PCS risk. Results demonstrated an 
adjusted OR 3.0, but failed to reach statistical significance on multivariate analysis.  
Hence, further studies are required to evaluate the effect of infection on PCS in TBI. 
 
Timing of Seizures 
 
Only one included study detailed the timing of PCS in relation to the cranioplasty14.  
Their data implies a bimodal distribution of PCS, with one peak in the first 24 hours 
and a second at over a week after cranioplasty, with less than 20% of the total 
occurring in the interim.  Delayed cranioplasty particularly increased risk of 
‘immediate’ and ‘early’ seizures (<24 hours and 24 hours to seven days, 
respectively), though the statistical significance of this observation was not 
reported14.  A study of PCS in 174 patients with mixed pathology found that over 
70% of PCS occurs within the first week after cranioplasty15, but another found no 
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such difference in incidence either side of a two-week cut off in 200 patients16.  
Further studies are required to fully understand the distribution of seizure timing after 
cranioplasty. Standardised definitions of ‘early’ and ‘late onset seizures will help 
meaningful data comparison.  
 
Use of anti-seizures medication 
 
None of the included studies evaluated the efficacy of anti-seizures medications in 
preventing PCS.  In most studies, it was not reported whether patients were routinely 
given prophylaxis.  Recent evidence in cohorts with mixed pathology suggests that 
prophylactic levetiracetam can significantly reduce the incidence of PCS16. Whether 
this applies for TBI remains to be elucidated.  
 
Limitations 
 
This systematic review is limited by (i) the paucity of studies evaluating PCS 
following TBI, and (ii) an even more limited number of studies exploring risk factors 
of PCS.  Included studies represent patients from wide-ranging locations, namely 
Australia23, India27, China14; 24; 25, Missouri18 and the UK26, in addition to one paper 
reporting on a military cohort from the US army4.  Varying treatment practices and 
mechanisms of trauma may affect generalisability of our findings. Furthermore, level 
of evidence is uniformly low. Only one study was of prospective design, but had a 
small sample size and follow-up for only one month post-cranioplasty27. Other 
studies demonstrate that this interval is insufficient for detecting the total incidence of 
PCS23. This prevents the differentiation between seizures as an isolated event 
following cranioplasty and a new diagnosis of epilepsy in included studies.  
 
Conclusions and future research 
 
Our review is the first of its type in the literature to systematically appraise the 
literature and identify risk factors of PCS in TBI patients. We herein report increasing 
age, contusion at the cranioplasty site, use of monopolar diathermy and use of 
autologous fascia at duraplasty as potentially significant risk factors. Further large, 
prospective cohort studies are required to evaluate (i) the true incidence of PCS; (ii) 
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whether delayed cranioplasty is truly predictive of PCS; and (iii) the validity of 
potential risk factors identified thus far.  Finally, randomised controlled trials are 
required to assess whether prophylactic administration of antiepileptics is beneficial 
in reducing the risk of PCS in TBI patients. 
 
 
 
Ethical Approval 
 
We confirm that we have read the Journal’s position on issues involved in ethical 
publication and affirm that this report is consistent with those guidelines. All co-
authors have seen and approved this version of the submission and will see and 
prove the final version for publication if necessary.  
 
 
 
References 
 
1. Jordan BD. The clinical spectrum of sport-related traumatic brain injury. Nat Rev Neurol 
2013;9:222-230. 
2. Ferguson PL, Smith GM, Wannamaker BB, et al. A population-based study of risk of 
epilepsy after hospitalization for traumatic brain injury. Epilepsia 2010;51:891-898. 
3. Honeybul S, Ho KM. Long-term complications of decompressive craniectomy for head 
injury. J Neurotrauma 2011;28:929-935. 
4. Stephens FL, Mossop CM, Bell RS, et al. Cranioplasty complications following wartime 
decompressive craniectomy. Neurosurgical Focus 2010;28:E3. 
5. Rosenthal G, Ng I, Moscovici S, et al. Polyetheretherketone implants for the repair of large 
cranial defects: a 3-center experience. Neurosurgery 2014;75:523-529; discussion 
528-529. 
6. Daou B, Zanaty M, Chalouhi N, et al. Low Incidence of Bone Flap Resorption After Native 
Bone Cranioplasty in Adults. World Neurosurg 2016;92:89-94. 
7. Piazza M, Grady MS. Cranioplasty. Neurosurg Clin N Am 2017;28:257-265. 
8. Honeybul S, Morrison DA, Ho KM, et al. A randomized controlled trial comparing 
autologous cranioplasty with custom-made titanium cranioplasty. Journal of 
Neurosurgery 2017;126:81-90. 
9. Shah AM, Jung H, Skirboll S. Materials used in cranioplasty: a history and analysis. 
Neurosurg Focus 2014;36:E19. 
10. Honeybul S, Morrison DA, Ho KM, et al. A randomised controlled trial comparing 
autologous cranioplasty with custom-made titanium cranioplasty: long-term follow-
up. Acta Neurochir (Wien) 2018;160:885-891. 
11. Malcolm JG, Rindler RS, Chu JK, et al. Complications following cranioplasty and 
relationship to timing: A systematic review and meta-analysis. J Clin Neurosci 
2016;33:39-51. 
 19 
12. Honeybul S. Complications of decompressive craniectomy for head injury. J Clin Neurosci 
2010;17:430-435. 
13. Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia 2003;44:18-20. 
14. Wang H, Zhang K, Cao H, et al. Seizure After Cranioplasty: Incidence and Risk Factors. 
Journal of Craniofacial Surgery 2017;28:e560-e564. 
15. Mukherjee S, Thakur B, Haq I, et al. Complications of titanium cranioplasty - A 
retrospective analysis of 174 patients. Acta Neurochirurgica 2014;156:989-998. 
16. Liang S, Ding P, Zhang S, et al. Prophylactic Levetiracetam for Seizure Control After 
Cranioplasty: A Multicenter Prospective Controlled Study. World Neurosurg 
2017;102:284-292. 
17. Zanaty M, Chalouhi N, Starke RM, et al. Complications following cranioplasty: incidence 
and predictors in 348 cases. Journal of Neurosurgery 2016;123:182-188. 
18. Pierson M, Birinyi PV, Bhimireddy S, et al. Analysis of Decompressive Craniectomies with 
Subsequent Cranioplasties in the Presence of Collagen Matrix Dural Substitute and 
Polytetrafluoroethylene as an Adhesion Preventative Material. World Neurosurg 
2016;86:153-160. 
19. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews 
and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. 
20. Wallace B, Dahebreh I, Trikalinos T, et al. Closing the gap between methodologists and 
end-users: R as a computational back-end. Journal of Statistical Software 2012;49:1-
15. 
21. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-
randomised studies of interventions. BMJ 2016;355:i4919. 
22. Group' OLoEW. The Oxford Levels of Evidence 2. In Editor (Ed)^(Eds) Book The Oxford 
Levels of Evidence 2, Oxford Centre for Evidence-Based Medicine; 2011. 
23. Honeybul S, Ho KM. Decompressive craniectomy for severe traumatic brain injury: the 
relationship between surgical complications and the prediction of an unfavourable 
outcome. Injury 2014;45:1332-1339. 
24. Luo J, Liu B, Xie Z, et al. Comparison of manually shaped and computer-shaped titanium 
mesh for repairing large frontotemporoparietal skull defects after traumatic brain 
injury. Neurosurg Focus 2012;33:E13. 
25. Zhang GL, Yang WZ, Jiang YW, et al. Extensive duraplasty with autologous graft in 
decompressive craniectomy and subsequent early cranioplasty for severe head 
trauma. Chinese Journal of Traumatology - English Edition 2010;13:259-264. 
26. Broughton E, Pobereskin L, Whitfield PC. Seven years of cranioplasty in a regional 
neurosurgical centre. Br J Neurosurg 2014;28:34-39. 
27. Songara A, Gupta R, Jain N, et al. Early Cranioplasty in Patients With Posttraumatic 
Decompressive Craniectomy and Its Correlation with Changes in Cerebral Perfusion 
Parameters and Neurocognitive Outcome. World Neurosurgery 2016;94:303-308. 
28. Chen F, Duan Y, Li Y, et al. Use of an antiepileptic drug to control epileptic seizures 
associated with cranioplasty: A randomized controlled trial. Int J Surg 2017;40:113-
116. 
29. Bender A, Heulin S, Röhrer S, et al. Early cranioplasty may improve outcome in 
neurological patients with decompressive craniectomy. Brain Inj 2013;27:1073-1079. 
30. Chibbaro S, Di Rocco F, Mirone G, et al. Decompressive craniectomy and early 
cranioplasty for the management of severe head injury: A prospective multicenter 
study on 147 patients. World Neurosurgery 2011;75:558-562. 
 20 
31. Sobani ZA, Shamim MS, Zafar SN, et al. Cranioplasty after decompressive craniectomy: 
An institutional audit and analysis of factors related to complications. Surg Neurol Int 
2011;2:123. 
32. Höhne J, Werzmirzowsky K, Ott C, et al. Outcomes of Cranioplasty with Preformed 
Titanium versus Freehand Molded Polymethylmethacrylate Implants. J Neurol Surg A 
Cent Eur Neurosurg 2018;79:200-205. 
33. Schuss P, Vatter H, Marquardt G, et al. Cranioplasty after decompressive craniectomy: 
the effect of timing on postoperative complications. J Neurotrauma 2012;29:1090-
1095. 
34. Faul M, Xu L, Wald M, et al. Traumatic Brain Injury in the United States. National Centre 
for Injury Prevention and Control 2010. 
35. Chang V, Hartzfeld P, Langlois M, et al. Outcomes of cranial repair after craniectomy. J 
Neurosurg 2010;112:1120-1124. 
36. Creutzfeldt CJ, Tirschwell DL, Kim LJ, et al. Seizures after decompressive 
hemicraniectomy for ischaemic stroke. J Neurol Neurosurg Psychiatry 2014;85:721-
725. 
37. Lee L, Ker J, Quah BL, et al. A retrospective analysis and review of an institution's 
experience with the complications of cranioplasty. Br J Neurosurg 2013;27:629-635. 
38. Riascos D, Buriticá E, Jiménez E, et al. Neurodegenerative diversity in human cortical 
contusion: histological analysis of tissue derived from decompressive craniectomy. 
Brain Res 2013;1537:86-99. 
39. Gooch MR, Gin GE, Kenning TJ, et al. Complications of cranioplasty following 
decompressive craniectomy: analysis of 62 cases. Neurosurg Focus 2009;26:E9. 
40. Sutton PA, Awad S, Perkins AC, et al. Comparison of lateral thermal spread using 
monopolar and bipolar diathermy, the Harmonic Scalpel and the Ligasure. Br J Surg 
2010;97:428-433. 
41. Hefermehl LJ, Largo RA, Hermanns T, et al. Lateral temperature spread of monopolar, 
bipolar and ultrasonic instruments for robot-assisted laparoscopic surgery. BJU Int 
2014;114:245-252. 
42. Krause-Titz UR, Warneke N, Freitag-Wolf S, et al. Factors influencing the outcome (GOS) 
in reconstructive cranioplasty. Neurosurg Rev 2016;39:133-139. 
43. Thien A, King NKK, Ang BT, et al. Comparison of polyetheretherketone and titanium 
cranioplasty after decompressive craniectomy. World Neurosurgery 2015;83:176-
180. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
